Healthcare & Life Sciences
Thymmune
United Statesthymmune.com
Thymmune is a startup based in the United States, most recent round Seed, 2 tracked investors.
Activeseed
seed
Stage
2021
Founded
2
Investors
About Thymmune
Thymmune is a company founded in 2021 headquartered in the United States. Its most recent tracked round is Seed. Brouky records 2 investors associated with the company.
Thymmune Therapeutics develops a machine learning-driven platform to engineer iPSC-derived thymic cells at scale, aiming to restore immune function in aging and disease by addressing thymus-related immune decline and disorders.
Explore Thymmune's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.